Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01124240
What this trial is testing

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene

Who this might be right for
Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
Northern Sydney and Central Coast Area Health Service 48
Early research (Phase 1)Ended earlyNCT02510950
What this trial is testing

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IV
Washington University School of Medicine 1
Testing effectiveness (Phase 2)Ended earlyNCT02227576
What this trial is testing

Prevention of Thrombocytopenia in Glioblastoma Patients

Who this might be right for
ThrombocytopeniaGlioblastoma
University Hospital, Lille 20
Testing effectiveness (Phase 2)Study completedNCT00028678
What this trial is testing

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 45
Testing effectiveness (Phase 2)Study completedNCT03466450
What this trial is testing

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 75
Testing effectiveness (Phase 2)Study completedNCT03746080
What this trial is testing

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcoma+2 more
Lawrence D Recht 21
Large-scale testing (Phase 3)UnknownNCT00045968
What this trial is testing

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Who this might be right for
Glioblastoma MultiformeGlioblastomaGBM+4 more
Northwest Biotherapeutics 348
Not applicableUnknownNCT02613988
What this trial is testing

Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

Who this might be right for
Adult Glioblastoma
Asan Medical Center 100
Early research (Phase 1)Ended earlyNCT00272870
What this trial is testing

Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Who this might be right for
Glioblastoma Multiforme (WHO Grade IV)Anaplastic Astrocytoma (WHO Grade III)
Children's Hospital Medical Center, Cincinnati 1
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Testing effectiveness (Phase 2)UnknownNCT04450160
What this trial is testing

Trial of AEO in New Glioblastoma (GBM)

Who this might be right for
Glioblastoma Multiforme
MetVital, Inc. 80
Early research (Phase 1)Study completedNCT03232424
What this trial is testing

NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma, Adult
Hackensack Meridian Health 12
Not applicableWithdrawnNCT04926168
What this trial is testing

6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)

Who this might be right for
MGMT-Methylated Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT03158389
What this trial is testing

NCT Neuro Master Match - N²M² (NOA-20)

Who this might be right for
Glioblastoma, Adult
University Hospital Heidelberg 228
Testing effectiveness (Phase 2)Study completedNCT00004200
What this trial is testing

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT01186406
What this trial is testing

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Duke University 41
Early research (Phase 1)Study completedNCT03389802
What this trial is testing

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Who this might be right for
Glioblastoma MultiformeHigh-grade Astrocytoma Not Otherwise Specified (NOS)CNS Primary Tumor, Not Otherwise Specified (NOS)+3 more
Pediatric Brain Tumor Consortium 32
Very early researchLooking for participantsNCT07387666
What this trial is testing

Imaging Acetadote Metabolism in Glioblastoma

Who this might be right for
GlioblastomaGBM
University of Texas Southwestern Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT04224441
What this trial is testing

Repurposing Chlorpromazine in the Treatment of Glioblastoma

Who this might be right for
Glioblastoma MultiformeMGMT-Unmethylated Glioblastoma
Marco G Paggi, MD, PhD 41
Large-scale testing (Phase 3)Study completedNCT01450449
What this trial is testing

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
International Atomic Energy Agency 115
Next Page